Skip to Main Content

sandoFor those needing help with your co-pay for LAR. Eligible Patients Pay No More Than a $25 Co-Pay per Sandostatin® LAR Depot Prescription Novartis Pharmaceuticals Corporation is committed to ensuring patient access to Sandostatin® LAR Depot (octreotide acetate for injectable suspension). With the Sandostatin LAR Depot Co-pay Card, eligible patients' co-pay may be no more than $25 per Sandostatin LAR Depot prescription. Novartis Pharmaceuticals Corporation will pay the remainder of the co-pay for their Sandostatin LAR Depot: For commercially insured patients, up to $15,000 per calendar year.

For more information please visit Novartis' website by clicking here.